news Update on the development of new novel cancer immunotherapy 24 May 2019 | By Drug Target Review The SCIB2 vaccine is to to be administered using new nanoparticle formulation in planned Phase 1/2 clinical trial.
news New study to develop a vaccine for glioblastoma multiforme 2 June 2016 | By Victoria White, Digital Content Producer Researchers have initiated a new preclinical study aimed at developing a vaccine for the treatment of glioblastoma multiforme using ImmunoBody technology...
news Collaboration to further explore the role of citrullinated proteins in cancer 11 March 2016 | By Victoria White Scancell is to collaborate with the Karolinska Institutet to explore the scientific and clinical role of citrullinated proteins in the treatment of cancer...